AstraZeneca antibody works to prevent, treat COVID-19 in longer-term studies -Breaking
[ad_1]
© Reuters. FILE PHOTO – Astra Zeneca Coronavirus vaccine Vaccine COVID-19 Coronavirus vaccine” is seen alongside a syringe and two vials labeled “Astra Zeneca COVID-19 Coronavirus Immune Vaccine”, in this illustration, taken March 14, 2021. REUTERS/Dado Ruvic(Reuters: AstraZeneca, NASDAQ:), announced Thursday that the COVID-19 Antibody Drug Cocktail reduced symptoms by 83%. It also reduced symptoms from worsening if given within 3 days.
Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.
[ad_2]
